「Drug Development」
- Bulletin Board
- Vaccine Infectious Diseases Drug Development
Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases such as Ebola Disease
- Bulletin Board
- Vaccine Infectious Diseases Research ＆ Development Drug Development
[Now open] GHIT Fund’s new Request for Proposals
- Special Member Event
- Research ＆ Development Drug Development Research Funding
Register Now! The 14th Proposal Writing and RFP Seminar (Zoom Webinar)
- Bulletin Board
- Infectious Diseases Drug Development
Total Investment of Approx. USD 18 Million in Malaria, Tuberculosis and NTD R&D Projects with Partners Including Shionogi, Eisai, Nagasaki, Ehime and Niigata University
- Bulletin Board
- Vaccine Drug Development
FunPep Co., Ltd. and Crafton Biotechnology Co., Ltd. Enter into Joint Research Agreement for Therapeutic mRNA Vaccines — Combining Antibody-Inducing Peptide Technology with Proprietary mRNA Technology
- Bulletin Board
- Infectious Diseases Drug Development
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects with Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
- Bulletin Board
- Vaccine Infectious Diseases Drug Development
Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
- Bulletin Board
- CDMO Nucleic Acid Medicine Drug Development
Luxna Deepens Collaboration with BioSpring to Advance Therapeutic Oligonucleotide Development